The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.
Abstract
BACKGROUND: The WHO MONICA Project is a 10-year study that monitors deaths due to coronary heart disease (CHD), acute myocardial infarction, coronary care, and risk factors in men and women aged 35 to 64 years in defined communities. This analysis of methods and results of coronary event registration in 1985 through 1987 provides data on the relation between CHD morbidity and mortality. METHODS AND RESULTS: Fatal and nonfatal coronary events were monitored through population-based registers. Hospital cases were found by pursuing admissions ("hot pursuit") or by retrospective analysis of discharges ("cold pursuit"). Availability of diagnostic data on identified nonfatal myocardial infarction was good. Information on fatal events (deaths occurring within 28 days) was limited and constrained in some populations by problems with access to sources such as death certificates. Age-standardized annual event rates for the main diagnostic group in men aged 35 to 64 covered a 12-fold range from 915 per 100,000 for North Karelia, Finland, to 76 per 100,000 for Beijing, China. For women, rates covered an 8.5-fold range from 256 per 100,000 for Glasgow, UK, to 30 per 100,000 for Catalonia, Spain. Twenty-eight-day case-fatality rates ranged from 37% to 81% for men (average, 48% to 49%), and from 31% to 91% for women (average, 54%). There was no significant correlation across populations for men between coronary event and case-fatality rates (r = -.04), the percentages of coronary deaths known to have occurred within 1 hour of onset (r = .08), or the percentages of known first events (r = -.23). Event and case-fatality rates for women correlated strongly with those for men in the same populations (r = .85, r = .80). Case-fatality rates for women were not consistently higher than those for men. For women, there was a significant inverse correlation between event and case-fatality rates (r = -.33, P < .05), suggesting that nonfatal events were being missed where event rates were low. Rankings based on MONICA categories of fatal events placed some middle- and low-mortality populations, such as the French, systematically higher than they would be based on official CHD mortality rates. However, rates for nonfatal myocardial infarction correlated quite well with the official mortality rates for CHD for the same populations. For men (age 35 to 64 years), approximately 1.5 (at low event rates) to 1 (at high event rates) episode of hospitalized, nonfatal, definite myocardial infarction was registered for every death due to CHD. The problem in categorizing deaths due to CHD was the large proportion of deaths with no relevant clinical or autopsy information. Unclassifiable deaths averaged 22% across the 38 populations but represented half of all registered deaths in 2 populations and a third or more of all deaths in 15 populations. CONCLUSIONS: The WHO MONICA Project, although designed to study longitudinal trends within populations, provides the opportunity for relating rates of validated CHD deaths to nonfatal myocardial infarction across populations. There are major differences between populations in nonfatal as well as fatal coronary event rates. They refute suggestions that high CHD mortality rates are associated with high case-fatality rates or a relative excess of sudden deaths. The high proportion of CHD deaths for which no diagnostic information is available is a cause for concern.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Cited by
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Long-term trends in the incidence of and survival with heart failure
Levy, D., Kenchaiah, S., Larson, M. G., Benjamin, E. J., Kupka, M. J., Ho, K. K. L., Murabito, J. M., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020265 · Cited by 2,152
Class of Antiretroviral Drugs and the Risk of Myocardial Infarction
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa062744 · Cited by 1,521
Tunstall-Pedoe, H., Kuulasmaa, K., Mähönen, M., Tolonen, H., & Ruokokoski, E. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04021-0 · Cited by 1,444
Self-citationLuepker, R. V. (1996) · JAMA · doi:10.1001/jama.1996.03530340032026 · Cited by 1,023
(2012) · doi:10.1016/s0140-6736(12)60994-5 · Cited by 1,001
Jousilahti, P., Vartiainen, E., Tuomilehto, J., & Puska, P. (1999) · Circulation · doi:10.1161/01.cir.99.9.1165 · Cited by 890
Fuster, V (1994) · Circulation · doi:10.1161/01.cir.90.4.2126 · Cited by 848
Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813
Association of apolipoprotein E genotypes with lipid levels and coronary risk
Bennet, A. M., Di Angelantonio, E., Ye, Z., Wensley, F., Dahlin, A., Ahlbom, A., Keavney, B., Collins, R., Wiman, B., de Faire, U., et al. (2007) · JAMA · doi:10.1001/jama.298.11.1300 · Cited by 794
(2015) · doi:10.1016/s0140-6736(15)60295-1 · Cited by 732
Wilson, B. J., Watson, M. S., Prescott, G. J., Sunderland, S., Campbell, D. M., Hannaford, P., & Smith, W. C. S. (2003) · BMJ · doi:10.1136/bmj.326.7394.845 · Cited by 723
Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
(2010) · The Lancet · doi:10.1016/s0140-6736(10)60545-4 · Cited by 716
Work stress and coronary heart disease: what are the mechanisms?
Chandola, T., Britton, A., Brunner, E., Hemingway, H., Malik, M., Kumari, M., Badrick, E., Kivimaki, M., & Marmot, M. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehm584 · Cited by 673
Thögersen, A. M., Jansson, J.-H., Boman, K., Nilsson, T. K., Weinehall, L., Huhtasaari, F., & Hallmans, G. (1998) · Circulation · doi:10.1161/01.cir.98.21.2241 · Cited by 602
Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial
Durazzo, A. E. S., Machado, F. S., Ikeoka, D. T., De Bernoche, C., Monachini, M. C., Puech-Leão, P., & Caramelli, B. (2004) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2004.01.004 · Cited by 595
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
Kimura, K., Kimura, T., Ishihara, M., Nakagawa, Y., Nakao, K., Miyauchi, K., Sakamoto, T., Tsujita, K., Hagiwara, N., Miyazaki, S., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0133 · Cited by 565
Iso, H., Kobayashi, M., Ishihara, J., Sasaki, S., Okada, K., Kita, Y., Kokubo, Y., & Tsugane, S. (2006) · Circulation · doi:10.1161/circulationaha.105.581355 · Cited by 557
Coffee, CYP1A2 genotype, and risk of myocardial infarction
Cornelis, M. C., El-Sohemy, A., Kabagambe, E. K., & Campos, H. (2006) · JAMA · doi:10.1001/jama.295.10.1135 · Cited by 490
Szummer, K., Wallentin, L., Lindhagen, L., Alfredsson, J., Erlinge, D., Held, C., James, S., Kellerth, T., Lindahl, B., Ravn-Fischer, A., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx515 · Cited by 443
Clark, A. G., Weiss, K. M., Nickerson, D. A., Taylor, S. L., Buchanan, A., Stengård, J., Salomaa, V., Vartiainen, E., Perola, M., Boerwinkle, E., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301977 · Cited by 435
Boscarino, J. A. (2008) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31817bccaf · Cited by 434
Gast, K. B., Tjeerdema, N., Stijnen, T., Smit, J. W. A., & Dekkers, O. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052036 · Cited by 403
Plasma Parathyroid Hormone and the Risk of Cardiovascular Mortality in the Community
Hagström, E., Hellman, P., Larsson, T. E., Ingelsson, E., Berglund, L., Sundström, J., Melhus, H., Held, C., Lind, L., Michaëlsson, K., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.808733 · Cited by 416
Risk of cause-specific death in individuals with diabetes: a competing risks analysis
Baena-Díez, J. M., Peñafiel, J., Subirana, I., Ramos, R., Elosua, R., Marín-Ibañez, A., Guembe, M. J., Rigo, F., Tormo-Díaz, M. J., Moreno-Iribas, C., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0614 · Cited by 384
Friis-Møller, N., Thiébaut, R., Reiss, P., Weber, R., D'Arminio Monforte, A., De Wit, S., El-Sadr, W., Fontas, E., Worm, S., Kirk, O., et al. (2010) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e328336a150 · Cited by 384
Better compliance to antihypertensive medications reduces cardiovascular risk
Corrao, G., Parodi, A., Nicotra, F., Zambon, A., Merlino, L., Cesana, G., & Mancia, G. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e328342ca97 · Cited by 367
van Dijk, E. J., Breteler, M. M. B., Schmidt, R., Berger, K., Nilsson, L.-G., Oudkerk, M., Pajak, A., Sans, S., de Ridder, M., Dufouil, C., et al. (2004) · Hypertension · doi:10.1161/01.hyp.0000145857.98904.20 · Cited by 345
Tunstall-Pedoe, H., Woodward, M., Tavendale, R., Brook, R. A., & McCluskey, M. K. (1997) · BMJ · doi:10.1136/bmj.315.7110.722 · Cited by 317
Self-citationRoerecke, M., & Rehm, J. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwp451 · Cited by 307
Hemingway, H., Crook, A. M., Feder, G., Banerjee, S., Dawson, J. R., Magee, P., Philpott, S., Sanders, J., Wood, A., & Timmis, A. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103013440906 · Cited by 262
(2015) · doi:10.1136/bmj.h3234 · Cited by 258
Everson, S. A., Lynch, J. W., Chesney, M. A., Kaplan, G. A., Goldberg, D. E., Shade, S. B., Cohen, R. D., Salonen, R., & Salonen, J. T. (1997) · BMJ · doi:10.1136/bmj.314.7080.553 · Cited by 232
Jennings, J. R., Kamarck, T. W., Everson-Rose, S. A., Kaplan, G. A., Manuck, S. B., & Salonen, J. T. (2004) · Circulation · doi:10.1161/01.cir.0000143840.77061.e9 · Cited by 229
Ekström, N., Schiöler, L., Svensson, A.-M., Eeg-Olofsson, K., Miao Jonasson, J., Zethelius, B., Cederholm, J., Eliasson, B., & Gudbjörnsdottir, S. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001076 · Cited by 221
Boscarino, J. A., & Chang, J. (1999) · Annals of Behavioral Medicine · doi:10.1007/bf02884839 · Cited by 216
Frystyk, J., Berne, C., Berglund, L., Jensevik, K., Flyvbjerg, A., & Zethelius, B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1067 · Cited by 201
Takii, T., Yasuda, S., Takahashi, J., Ito, K., Shiba, N., Shirato, K., Shimokawa, H., & on behalf of the MIYAGI-AMI Study Investigators (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0619 · Cited by 196
Eeg‐Olofsson, K., Cederholm, J., Nilsson, P. M., Zethelius, B., Svensson, A. ‐., Gudbjörnsdóttir, S., & Eliasson, B. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02265.x · Cited by 178
Coffee Consumption and the Risk of Coronary Heart Disease and Death
Kleemola, P., Jousilahti, P., Pietinen, P., Vartiainen, E., & Tuomilehto, J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.22.3393 · Cited by 177
Risk Prediction of Cardiovascular Disease in Type 2 Diabetes
Cederholm, J., Eeg-Olofsson, K., Eliasson, B., Zethelius, B., Nilsson, P. M., Gudbjörnsdottir, S., & Register, O. B. O. T. S. N. D. (2008) · Diabetes Care · doi:10.2337/dc08-0662 · Cited by 173
Trends in Stroke and Coronary Heart Disease in the WHO MONICA Project
Truelsen, T., Mähönen, M., Tolonen, H., Asplund, K., Bonita, R., & Vanuzzo, D. (2003) · Stroke · doi:10.1161/01.str.0000069724.36173.4d · Cited by 157
Atkinson, C., Warren, R. M., Sala, E., Dowsett, M., Dunning, A. M., Healey, C. S., Runswick, S., Day, N. E., & Bingham, S. A. (2004) · Breast Cancer Research · doi:10.1186/bcr773 · Cited by 151
Rumana, N., Kita, Y., Turin, T. C., Murakami, Y., Sugihara, H., Morita, Y., Tomioka, N., Okayama, A., Nakamura, Y., Abbott, R. D., et al. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn064 · Cited by 121
Role of echocardiography in the evaluation of syncope: a prospective study
Sarasin, F. P., Junod, A.-F., Carballo, D., Slama, S., Unger, P.-F., & Louis-Simonet, M. (2002) · Heart · doi:10.1136/heart.88.4.363 · Cited by 120
for the JPHC Study Group, Noda, H., Iso, H., Saito, I., Konishi, M., Inoue, M., & Tsugane, S. (2009) · Hypertension Research · doi:10.1038/hr.2009.14 · Cited by 116
Eshak, E. S., Iso, H., Kokubo, Y., Saito, I., Yamagishi, K., Inoue, M., & Tsugane, S. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.037903 · Cited by 111
Nakatani, D., Sakata, Y., Suna, S., Usami, M., Matsumoto, S., Shimizu, M., Sumitsuji, S., Kawano, S., Ueda, Y., Hamasaki, T., et al. (2013) · Circulation Journal · doi:10.1253/circj.cj-11-1059 · Cited by 108
Effect of retirement on cognitive function: the Whitehall II cohort study
Xue, B., Cadar, D., Fleischmann, M., Stansfeld, S., Carr, E., Kivimäki, M., McMunn, A., & Head, J. (2018) · European Journal of Epidemiology · doi:10.1007/s10654-017-0347-7 · Cited by 102
Transient Exposure to Coffee as a Trigger of a First Nonfatal Myocardial Infarction
Baylin, A., Hernandez-Diaz, S., Kabagambe, E. K., Siles, X., & Campos, H. (2006) · Epidemiology · doi:10.1097/01.ede.0000229444.55718.96 · Cited by 104
Women's hearts need special treatment
Burell, G., & Granlund, B. (2002) · International Journal of Behavioral Medicine · doi:10.1207/s15327558ijbm0903_05 · Cited by 103
Nigam, A., Wright, R. S., Allison, T. G., Williams, B. A., Kopecky, S. L., Reeder, G. S., Murphy, J. G., & Jaffe, A. S. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.06.040 · Cited by 98
Cederholm, J., Eeg-Olofsson, K., Eliasson, B., Zethelius, B., Gudbjörnsdottir, S., & Register, O. B. O. T. S. N. D. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03342.x · Cited by 90
Baba, S., Iso, H., Mannami, T., Sasaki, S., Okada, K., Konishi, M., & Tsugane, S. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000194417.16638.3d · Cited by 79
Risk factors for development of coronary artery disease in women with systemic lupus erythematosus
GOLDBERG, R. J., UROWITZ, M. B., IBAÑEZ, D., NIKPOUR, M., & GLADMAN, D. D. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090011 · Cited by 78
Sex Differences in the Contributions of Visceral and Total Body Fat to Blood Pressure in Adolescence
Pausova, Z., Mahboubi, A., Abrahamowicz, M., Leonard, G. T., Perron, M., Richer, L., Veillette, S., Gaudet, D., & Paus, T. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.180372 · Cited by 70
Clonal Hematopoiesis: Somatic Mutations in Blood Cells and Atherosclerosis
Natarajan, P., Jaiswal, S., & Kathiresan, S. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.118.001926 · Cited by 63
Jonsdottir (2002) · Journal of Cardiovascular Risk · doi:10.1097/00043798-200204000-00001 · Cited by 61
Kohsaka, S., Kimura, T., Goto, M., Lee, V.-V., Elayda, M., Furukawa, Y., Fukushima, M., Komeda, M., Sakata, R., Willerson, J. T., et al. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.01.349 · Cited by 60
Virtanen, J. K., Laukkanen, J. A., Mursu, J., Voutilainen, S., & Tuomainen, T.-P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041046 · Cited by 48
Iso, H., Noda, H., Ikeda, A., Yamagishi, K., Inoue, M., Iwasaki, M., & Tsugane, S. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11999 · Cited by 48
Yatsuya, H., Iso, H., Li, Y., Yamagishi, K., Kokubo, Y., Saito, I., Sawada, N., Inoue, M., & Tsugane, S. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0081 · Cited by 47
Wu, Z., Lou, Y., Qiu, X., Liu, Y., Lu, L., Chen, Q., & Jin, W. (2014) · BMC Medical Genetics · doi:10.1186/s12881-014-0118-1 · Cited by 40
“MI was defined by the World Health Organization’s Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (MONICA) criteria [29].”
Nozue, M., Shimazu, T., Charvat, H., Mori, N., Mutoh, M., Sawada, N., Iwasaki, M., Yamaji, T., Inoue, M., Kokubo, Y., et al. (2021) · European Journal of Clinical Nutrition · doi:10.1038/s41430-020-00732-1 · Cited by 42
Trends in the prevalence, awareness, treatment and control of hypertension: the WHO MONICA Project
Antikainen, R. L., Moltchanov, V. A., Chukwuma, C., Kuulasmaa, K. A., Marques-Vidal, P. M., Sans, S., Wilhelmsen, L., & Tuomilehto, J. O. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/00149831-200602000-00004 · Cited by 132
Self-citationElbaz, A., Shipley, M. J., Nabi, H., Brunner, E. J., Kivimaki, M., & Singh-Manoux, A. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.12.051 · Cited by 38
Saito, I., Kokubo, Y., Yamagishi, K., Iso, H., Inoue, M., & Tsugane, S. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.01.021 · Cited by 38
Corrao, G., Scotti, L., Zambon, A., Baio, G., Nicotra, F., Conti, V., Capri, S., Tragni, E., Merlino, L., Catapano, A. L., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.04.014 · Cited by 33
Stringhini, S., Sinon, F., Didon, J., Gedeon, J., Paccaud, F., & Bovet, P. (2012) · Stroke · doi:10.1161/strokeaha.112.658468 · Cited by 31
Tanaka, F., Makita, S., Onoda, T., Tanno, K., Ohsawa, M., Itai, K., Sakata, K., Omama, S.-I., Yoshida, Y., Ogasawara, K., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.05.049 · Cited by 19
Metadata
- Authors
- Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A. M., & Pajak, A.
- Venue
- Circulation
- Published
- 1994-07
- Volume
- 90
- Issue
- 1
- Pages
- 583-612
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2031498851
- Cited by
- 2,263
- References
- 1
- FWCI
- 44.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.